Verify patient identity and side of procedure. Confirm absence of local or systemic infection. Review coagulation profile if patient is on anticoagulants. Obtain informed consent. Position the patient in a lateral decubitus position with the affected side up.
Advise the patient to avoid strenuous activity or high-impact exercise for 48 hours. Monitor for immediate post-injection pain or allergic reaction. Discharge immediately after ensuring patient stability. Apply ice packs if discomfort occurs. Follow up in 2-4 weeks to assess symptom relief.
Comprehensive Clinical Guide: Trochanteric Bursa Injection (Steroid)
1. Introduction and Overview
Greater Trochanteric Pain Syndrome (GTPS), historically referred to as trochanteric bursitis, represents a common clinical entity characterized by lateral hip pain. While the pathophysiology is often multifactorial—involving tendinopathy of the gluteus medius and minimus, as well as inflammation of the trochanteric bursa—the trochanteric bursa injection remains a cornerstone of conservative management.
This procedure involves the precise delivery of a corticosteroid, often combined with a local anesthetic, into the potential space between the greater trochanter of the femur and the overlying iliotibial band (ITB) and gluteal muscles. The primary therapeutic goal is the rapid reduction of local inflammation, thereby facilitating physical therapy and long-term functional rehabilitation.
2. Technical Specifications and Mechanism of Action
The Anatomy of the Trochanteric Space
The greater trochanteric bursa is one of the largest bursae in the body. It acts as a synovial-lined cushion that minimizes friction between the bony prominence of the femur and the overlying soft tissues. When this space becomes hyperemic or distended due to repetitive microtrauma, biomechanical imbalances, or inflammatory processes, it results in the classic lateral hip pain pattern.
Pharmacological Mechanism
The injection typically utilizes a combination of:
* Local Anesthetic (e.g., Lidocaine 1% or Bupivacaine 0.5%): Provides immediate diagnostic confirmation (if pain resolves instantly) and short-term analgesic relief.
* Corticosteroid (e.g., Triamcinolone or Methylprednisolone): A potent anti-inflammatory agent. Steroids inhibit the enzyme phospholipase A2, thereby blocking the arachidonic acid cascade. This decreases the production of prostaglandins and leukotrienes, reducing capillary permeability and suppressing the migration of polymorphonuclear leukocytes to the injection site.
3. Extensive Clinical Indications and Usage
Indications for Procedure
The procedure is indicated for patients who have failed initial conservative measures, including activity modification, non-steroidal anti-inflammatory drugs (NSAIDs), and supervised physical therapy.
| Clinical Presentation | Specific Diagnostic Criteria |
|---|---|
| Lateral Hip Pain | Tenderness precisely at the greater trochanter |
| Pain with Adduction | Pain exacerbated when the hip is moved toward the midline |
| Sleep Disturbance | Inability to lie on the affected side |
| Gait Abnormalities | Antalgic gait caused by gluteal weakness/pain |
Patient Pre-Operative Preparation
- Informed Consent: Discuss risks (infection, atrophy, flare) vs. benefits.
- Anticoagulation Review: While superficial, clinicians must assess if the patient is on therapeutic anticoagulation, though standard injections rarely require cessation.
- Site Marking: Palpation to identify the point of maximal tenderness is critical.
- Aseptic Technique: Strict adherence to skin preparation using chlorhexidine or povidone-iodine is mandatory to prevent septic bursitis.
4. The Procedure: Step-by-Step Intervention
The procedure is traditionally performed in an outpatient setting, often guided by ultrasound for increased accuracy.
- Positioning: The patient is placed in the lateral decubitus position with the affected side up, or supine with a slight bolster under the hip.
- Ultrasound Guidance: Using a high-frequency linear transducer, the clinician identifies the cortical bone of the greater trochanter and the overlying IT band.
- Anesthesia: A small wheal of local anesthetic is raised at the entry point.
- Needle Placement: A 22- or 25-gauge needle is advanced toward the bursa. If using ultrasound, the "in-plane" technique allows for real-time visualization of the needle tip entering the bursal space.
- Aspiration/Injection: If fluid is present, it may be aspirated for analysis if infection is suspected. The corticosteroid/anesthetic mixture is then injected slowly. Resistance should be minimal; if high resistance is felt, the needle is likely within the tendon or muscle, not the bursa.
- Post-Injection: The needle is withdrawn, and a sterile dressing is applied.
5. Post-Operative Recovery Protocol
The recovery phase is as important as the injection itself. Patients should be advised on the following:
- Immediate Post-Op (0–48 hours): Relative rest. Avoid high-impact activities. Ice packs may be applied to the site for 15 minutes every few hours to manage post-injection soreness.
- The "Steroid Flare": Patients should be informed that pain might increase temporarily within the first 24–48 hours as the body reacts to the crystalline nature of the steroid.
- Physical Therapy (Days 3–14+): The injection is a "window of opportunity." The reduction in pain allows for the initiation of hip abductor strengthening, IT band stretching, and correction of pelvic alignment.
- Monitoring: Follow-up in 4–6 weeks to assess the duration of relief and the need for further intervention.
6. Risks, Side Effects, and Contraindications
While generally safe, clinicians must be vigilant regarding potential adverse events.
Common Side Effects
- Post-injection flare: Self-limiting, occurs in 10-20% of patients.
- Local skin hypopigmentation or atrophy: Risk increases with higher concentrations of steroids or repeated injections in the same site.
- Facial flushing: A systemic, benign reaction to corticosteroids.
Serious Risks
- Septic Bursitis: Rare, but requires urgent surgical debridement and IV antibiotics.
- Tendon Rupture/Weakness: Excessive or frequent injections can weaken the gluteal tendons.
- Systemic Hyperglycemia: A concern for diabetic patients; blood glucose should be monitored for 48 hours post-injection.
Contraindications
- Known allergy to local anesthetics or corticosteroids.
- Active infection at the site or systemic sepsis.
- Uncontrolled diabetes mellitus (relative contraindication).
- Severe coagulation disorders.
7. Alternative Treatments
If the steroid injection provides only transient relief, the following alternatives should be considered:
- Platelet-Rich Plasma (PRP) Therapy: Autologous blood product injections to promote tissue healing in cases of chronic gluteal tendinopathy.
- Extracorporeal Shockwave Therapy (ESWT): Uses high-energy sound waves to stimulate the healing of the tendon-bone interface.
- Surgical Intervention: Endoscopic bursectomy and IT band release are reserved for chronic, refractory cases where conservative measures have failed for 6–12 months.
- Dry Needling: Often used by physical therapists to address trigger points in the gluteal muscles that mimic bursitis.
8. Massive FAQ Section
Q1: How long does the injection take to work?
A: The anesthetic component provides relief within minutes. The steroid component typically begins to exert its anti-inflammatory effect within 48 to 72 hours, with peak efficacy at 2 weeks.
Q2: How many injections can I have?
A: It is generally recommended to limit injections to three per year in the same location to avoid the risk of tendon weakening or skin atrophy.
Q3: Will this injection cure my hip pain forever?
A: The injection treats the inflammation, not the underlying biomechanical cause. Without physical therapy to address weak gluteal muscles or gait issues, the pain is likely to return.
Q4: Is the procedure painful?
A: Most patients describe the sensation as a "pinch" or "pressure." The use of a local anesthetic skin wheal significantly reduces discomfort.
Q5: Can I drive home after the procedure?
A: Yes, as long as the injection was only in the hip and did not involve heavy sedation.
Q6: What if I am diabetic?
A: Corticosteroids can transiently elevate blood sugar levels. Diabetic patients should monitor their glucose levels closely for 48 hours and consult their primary care physician if levels remain elevated.
Q7: Is ultrasound guidance necessary?
A: While "blind" injections are historically common, studies suggest that ultrasound guidance significantly improves accuracy, ensuring the medication is placed within the bursa rather than the surrounding muscle.
Q8: What is "Steroid Flare"?
A: It is a temporary increase in pain caused by the irritation of the crystalline steroid particles before they are absorbed. It usually resolves within 48 hours with ice and rest.
Q9: Can this injection cause weight gain?
A: Systemic absorption of steroids can lead to fluid retention or appetite changes, but this is extremely rare with a single local hip injection.
Q10: What should I do if my pain gets worse after a week?
A: If pain worsens significantly or is accompanied by fever, redness, or warmth at the site, you must contact your provider immediately to rule out infection.
9. Conclusion
The Trochanteric Bursa Injection remains a highly effective, minimally invasive therapeutic tool for managing lateral hip pain. By integrating precise ultrasound-guided delivery with a structured post-procedural rehabilitation program, clinicians can achieve excellent outcomes in reducing pain and restoring patient functionality. Success relies heavily on the patient's commitment to physical therapy following the resolution of acute inflammation.